Which EHR Pilot Success Metrics Should Care Organizations Measure Before Scaling in 2026?

The Direct Answer: What Makes an EHR Pilot Successful?

An EHR pilot succeeds when it proves that a new workflow or digital patient-pulse capability works in everyday clinical operations, produces measurable value, is safe, and can be supported at the intended scale. The most defensible EHR pilot success metrics therefore combine adoption, workflow, patient experience, operational efficiency, data quality, financial performance, and clinical outcomes. Adoption alone is weak evidence: a tool can reach 90% of eligible accounts while generating few completed actions, distracting clinicians, or creating unreviewed alerts. A better pilot asks whether users acted as intended, whether the action was completed correctly, and whether the result improved care or reduced avoidable work.

Also worth reading: How Can Healthcare Organizations Improve Vendor Evaluation for Safer Care Coordination? · How Should Clinics Measure Referral Workflow Metrics in 2026? · How Do Prior Authorization Pilot Metrics Reveal AI Impacts Across Medicare?

A practical primary target is at least 80% weekly active use among the staff group the product is designed to support, with 70% or more of eligible patient encounters or accounts generating a completed workflow. Alongside usage, teams should set thresholds such as a 15% reduction in manual follow-up time, a 10% improvement in response closure within two business days, or at least a 5-percentage-point increase in outreach completion. These are management targets rather than universal clinical standards; the right threshold depends on baseline performance, patient risk, staffing, and the cost of the intervention. The pilot should run long enough to observe routine variation, seasonality, onboarding effects, and repeat use rather than relying on a short demonstration period.

For getpulse.care and similar care-coordination platforms, the central issue is not whether a dashboard displays patient signals. It is whether clinics and care networks can turn those signals into timely, documented action without adding unreliable work. A successful pilot should connect a measured signal to an owner, a response time, a resolution status, and an auditable outcome. That chain is what distinguishes operational adoption from theatrical activity.

Metric Framework: What Should a Care Organization Measure?

A balanced scorecard prevents a pilot from being judged on only one favorable indicator. Usage metrics should include unique users, frequency, eligible-user penetration, and completion of the intended action. Workflow metrics can measure time to acknowledgment, escalation, outreach, documentation, and closure. Quality controls should assess duplicate records, false or poorly characterized signals, missed escalations, and the percentage of actions with a clear clinical rationale. Patient-experience measures can cover perceived responsiveness, communication, access, and satisfaction, while operational metrics should track calls, status checks, manual handoffs, and staff workload.

The baseline matters as much as the result. If a clinic currently contacts 60% of high-risk patients within 48 hours, a credible pilot target might be 80% within the same window. If median manual review already takes 12 minutes, reducing it to 9 minutes would represent a 25% improvement. Absolute percentages without a baseline often hide whether change was meaningful. Teams should record at least four to eight weeks of baseline data, then compare the pilot with both the baseline and a comparable non-pilot group where feasible.

Clinical outcomes should be included only when the intervention and observation period can plausibly affect them. A 60- to 90-day pilot may show faster outreach and better closure of care gaps, but it may not safely establish fewer admissions, readmissions, or disease complications. Those outcomes often require months of follow-up and careful adjustment for case mix. For early decisions, leading indicators such as completed outreach, closed care gaps, avoided duplicate contacts, and documented escalation are usually more informative than distant hospital utilization measures.

## Adoption, Engagement, and Workflow Efficiency

Adoption should be defined by behavior, not licenses, seats purchased, or accounts provisioned. A useful scorecard separates enrolled users from weekly active users, then separates those users from cases completed without manual rescue. For a care-coordination pilot, the denominator should generally be eligible patients or accounts rather than all patients in the EHR. This avoids making performance appear weak merely because most patients were not appropriate candidates for the workflow.

Efficiency gains should be calculated in minutes, touches, and handoffs saved. Before launch, measure the median staff time required to identify a patient, review context, assign an owner, make contact, document the response, and close the task. During the pilot, compare completed cycles and failure points rather than only average handling time. A reduction from 14 minutes to 8 minutes per case is a 43% improvement, but that benefit is only valuable if completed volume rises or staff can redirect the six minutes to other duties.

Time thresholds can be tailored to risk. Routine outreach might be expected within three business days, while urgent deterioration signals may require acknowledgment within 15 to 30 minutes, depending on the product and clinical protocol. A clinic should not invent an unsafe urgency standard for software-generated signals. It must define which signals are advisory, which require human review, and which trigger a clinical escalation pathway. The EHR pilot is unsuccessful if faster software processing pushes ambiguous alerts to staff faster than they can safely assess them.

A practical scale-readiness threshold is at least 90% of users completing role-based training and 85% of eligible cases assigned an accountable owner. Performance should also be stable across at least four consecutive weeks, not concentrated during the first week when a champion is highly engaged. The target organization should examine day-versus-night results, physician versus nurse workflows, and high-volume versus low-volume sites because averages can conceal dangerous variation.

Data Quality, Safety, and Clinical Reliability

Data quality is an outcome of the pilot, not a precondition that can be ignored. Teams should measure the percentage of signals containing complete demographics, contact information, encounter context, provenance, and a usable timestamp. They should also count missing values, duplicate signals, stale information, mismatched identifiers, and cases routed to the wrong team. Depending on the environment, even a 2% duplicate rate can create substantial extra work when applied to thousands of accounts.

Safety measurement requires a clear human-review process. Any recommendation, risk score, outreach prompt, or prioritization should be traceable to its source and intended use. Users need to know whether the software surfaces information, ranks work, predicts risk, or makes a clinical decision. For most early-stage coordination pilots, predictive outputs should be checked for performance across age, sex, language, disability, race or ethnicity, insurance status, and relevant clinical groups when sample sizes permit.

Before scale, a responsible pilot team should establish that high-severity cases have a named escalation path, critical alerts are reviewed promptly, and every action is auditable in the EHR or an approved connected system. The team should also define what happens when the vendor is unavailable or data is delayed. An acceptable target may be at least 99% successful synchronization for non-emergency data, with downtime procedures tested at least once during the pilot. These numbers are proposed operating thresholds, not proof that a platform is clinically safe.

A pilot should stop or pause if it creates a confirmed material safety event, persistent unaddressed data loss, or escalation failure at a scale the team cannot review. A lower alert-precision target of 80% may be acceptable for a low-burden administrative task but poor for an interruptive clinical alert that creates alert fatigue. The appropriate burden depends on consequence and reversibility, so no single accuracy percentage fits every use case.

Patient Experience, Access, and Care-Network Performance

Patient-centered metrics determine whether improved internal workflow is visible outside the organization. Clinics can measure outreach completion, time to first contact, missed-appointment recovery, successful resolution, patient-reported understanding, and complaints. Because satisfaction surveys often have low response rates, operational measures should be paired with a short validated survey or structured follow-up rather than treated as the sole outcome.

A useful pilot might aim for a 10% increase in successful contact among patients previously difficult to reach, a 15% reduction in abandoned outreach, or a five-percentage-point improvement in patients reporting that they knew how to obtain help. These targets should be tied to a defined population and period. For example, measuring satisfaction among only patients who completed a survey creates survivorship bias because the least satisfied or hardest-to-reach people may not respond.

For care networks, local performance can hide coordination failures between sites. The evaluation should show whether shared patients received consistent processes, whether duplicate outreach was reduced, and whether responsibility remained clear after transfer of care. Networks should compare sites using both overall results and the gap between the best and worst site. A network average of 80% with one site at 42% may warrant more investigation than two sites consistently operating near 75%.

Equity should be tested as part of the pilot rather than deferred until after rollout. Review contact success, time to response, false-positive burden, and closure rates by language, age, disability status, deprivation proxy, and other locally relevant factors where privacy and sample size allow. A tool that raises the network average while widening gaps for a particular group is not an unqualified success. The purpose of this analysis is to improve design and access, not to assume that every observed difference proves algorithmic bias.

Cost, Pricing, Return, and Scale Economics

Pricing for EHR-integrated pilot software varies by data depth, integration work, patient volume, number of sites, support requirements, and clinical use. A clinic should price the complete pilot rather than comparing subscription fees alone. Relevant costs include implementation, interface development or configuration, identity management, security review, training, clinical time, monitoring, downtime procedures, and ongoing administration. Vendors may offer a low pilot price while excluding the work required to make results reliable.

As a planning framework—not a vendor quote—a small evaluation may cost several thousand dollars, while a multi-site integration and evaluation can reach tens of thousands or more. The observed context that only 5 of 150 VA medical centers had piloted a new EHR system by March 2023, about 3%, illustrates how large deployments can stall before reaching routine adoption. It does not establish the cost of current software, but it shows why technical selection and organizational readiness must be treated separately.

Return on investment should be calculated from documented baseline variables: staff hours, outreach completion, avoided duplicate contacts, reduced unpaid follow-up, faster access, or better use of contracted capacity. If a pilot saves 1,000 hours at a fully loaded labor rate of $45, the theoretical labor value is $45,000, but that is not automatically net savings. The team should subtract license, integration, review, training, and maintenance costs, and avoid assigning monetary value to clinical outcomes that were not causally demonstrated.

A defensible scale decision can require positive projected net benefit within 12 to 24 months, full implementation funding, no unresolved safety defect, and at least 80% of sites meeting agreed performance thresholds. A pilot that shows clinical promise but weak economics may remain useful for research or a narrow safety program. It should not be labeled a scalable business success unless the organization can explain how recurring costs will be covered.

Practical Steps: How to Run a Defensible 90-Day Pilot

First, define one primary workflow and one accountable executive sponsor. For example, the objective might be to improve outreach for patients with selected care-coordination gaps, not to deploy an all-purpose “AI platform.” Establish a baseline for at least four weeks, and document eligible volume, staff time, response time, completion rate, duplicate contacts, and patient experience. Select pilot sites with a mix of conditions so the result is not based only on the most enthusiastic team.

Second, agree in writing on success thresholds, data definitions, exclusions, safety events, and the decision date. Use an 8- to 12-week pilot with at least four stable weeks of operation and a final 30-day follow-up where possible. A 90-day calendar plan might allocate two weeks for governance and baseline confirmation, two for configuration and training, six to eight for live use, and two for analysis and a scale recommendation. Long implementation work should not be counted as live performance time.

Third, run weekly operational reviews rather than waiting for the final report. Review adoption, completed workflows, failed actions, alert burden, staff feedback, safety events, and data defects. Assign an owner and due date to every issue, and distinguish issues that can be corrected from fundamental workflow problems. At week four, pause expansion if the team cannot safely review the signal volume or if false and duplicate work is rising faster than expected.

Fourth, perform independent analysis at the end. Compare the pilot group with baseline and, where possible, a matched non-pilot group. Report confidence intervals or other uncertainty measures when sample sizes allow, and include unfavorable results. The final decision should have four possible outcomes: scale, extend for corrective work, stop, or use only in a narrow setting. Predefining these choices reduces pressure to describe an inconclusive pilot as successful.

Comparison of Success Metrics and Common Pilot Mistakes

The best metric depends on the question being tested. Login counts are suitable for evaluating awareness, not clinical value. A model-discrimination measure may be suitable for evaluating a predictive task, but it does not prove that using the model improves care. Patient satisfaction is important, yet it is influenced by service quality outside the software. A strong evaluation triangulates several categories instead of allowing one impressive number to determine the entire result.

Common mistakes include selecting users who cannot influence the workflow, measuring activity without a denominator, changing targets after poor results, and treating incomplete pilot periods as stable. Teams also fail when they count software-generated outreach as completed outreach, omit staff time from the business case, or neglect the work required to reconcile data across systems. Another error is assuming that broader rollout will fix low adoption; it usually multiplies the original problem.

Leadership should require an audit trail showing how each reported figure was calculated. Definitions should be stable across the pilot, and revisions should be documented. Subjective feedback is also evidence, but it should be collected systematically through interviews, observations, or structured surveys. A product can be technically functional while forcing clinicians to reproduce its work elsewhere, which means integration and workflow design remain part of performance.

When to Scale, Extend, or Stop the Pilot

Scale when the improvement is large enough to matter, repeatable across ordinary weeks and representative sites, and safe under the proposed operating model. By 2026, a reasonable default evidence package is at least 80% weekly active use, 70% or higher completion among eligible cases, no unresolved material safety event, stable data quality, and a predeclared improvement in one workflow, patient, or financial outcome. These are decision aids, not certification standards. A lower threshold may be reasonable for a narrow or advisory workflow, while a higher threshold may be needed for direct clinical or urgent operations.

Extend the pilot when evidence is promising but the defect is correctable, such as a poor owner-assignment rule, incomplete staff training, or a delayed interface. Specify a 30- to 60-day corrective period and require new data from the affected period. Do not average away defects discovered early. The decision to extend should include a clear cost limit, named owner, and explicit statement of what evidence would support scale afterward.

Stop when the workflow cannot produce value within a realistic evaluation period, users consistently route around it, staff burden exceeds the benefit, or governance cannot make the signal safe and accountable. Early stopping is not a failure of measurement; it prevents expensive deployment based on weak evidence. Document what was learned and whether a different population, workflow, or integration design deserves evaluation.

A pilot should not be approved for enterprise scale merely because the vendor has a polished interface, an impressive model metric, or a large customer list. By September 2026, healthcare buyers can reasonably expect stronger evidence: local baselines, transparent denominators, subgroup analysis, implementation cost, safety controls, and independent review of material claims. The best EHR pilot success metrics form a chain from reliable data to user action to patient and operational result. If any link in that chain is missing, the organization should describe the result narrowly and avoid turning a limited study into a broad claim.

The practical answer is therefore not one universal number. It is a predeclared scorecard with clinical, operational, patient, data, safety, and economic evidence collected over enough time to reveal routine performance. That discipline gives clinics and care networks a defensible basis for deciding whether to scale, revise, narrow, or stop an EHR pilot.